万孚生物(300482) - 2024 Q3 - 季度财报

Financial Performance - Revenue for the third quarter reached 606.11 million yuan, a year-on-year increase of 17.51%[2] - Net profit attributable to shareholders of the listed company was 80.14 million yuan, up 22.70% year-on-year[2] - Operating cash flow for the first three quarters was 173.32 million yuan, a significant increase of 577.95% year-on-year[2] - Total operating income reached 2,181,361,474.64 RMB, compared to 2,004,422,655.85 RMB in the same period last year[14] - Net profit attributable to the parent company's owners rose to 3,420,009,443.28 RMB, up from 3,171,439,111.97 RMB[13] - Net profit attributable to parent company shareholders reached 435.94 million yuan, a year-on-year increase of 9.04%[15] - Operating profit increased to 498.11 million yuan, up 7.64% compared to the same period last year[15] - Basic earnings per share (EPS) stood at 0.94 yuan, a 3.30% increase from the previous year[16] - Total comprehensive income amounted to 439.59 million yuan, reflecting a 9.93% year-on-year growth[16] - Sales revenue from goods and services reached 1.87 billion yuan, a 2.69% increase compared to the same period last year[17] Assets and Liabilities - Total assets as of the end of the reporting period were 6.75 billion yuan, an increase of 16.95% compared to the end of the previous year[2] - Total assets increased to 6,750,053,993.88 RMB, up from 5,771,717,185.26 RMB in the previous period[12][13] - Total liabilities stood at 1,183,419,313.40 RMB, slightly higher than 1,157,093,084.26 RMB in the previous period[13] - Fixed assets increased to 1,282,158,369.63 RMB, up from 1,016,780,459.03 RMB[12] - Long-term equity investments grew to 443,241,958.45 RMB, compared to 406,358,589.06 RMB[12] - Total equity attributable to the parent company's owners rose to 5,470,222,938.09 RMB, up from 4,515,967,763.10 RMB[13] - The company's monetary funds decreased by 68.56%, mainly due to increased investment in financial products[5] - The company's monetary funds decreased from 840,297,176.03 yuan at the beginning of the period to 264,158,244.73 yuan at the end of the period[11] - The company's trading financial assets increased from 722,446,137.96 yuan at the beginning of the period to 1,850,756,466.78 yuan at the end of the period[11] - The company's accounts receivable increased from 598,217,984.70 yuan at the beginning of the period to 884,077,440.58 yuan at the end of the period[11] - The company's inventory increased from 351,400,529.24 yuan at the beginning of the period to 390,925,976.28 yuan at the end of the period[11] - The company's other current assets decreased from 650,344,551.61 yuan at the beginning of the period to 274,961,521.60 yuan at the end of the period[11] Expenses and Costs - The company's financial expenses increased by 227.46% year-on-year, mainly due to exchange rate fluctuations[5] - Operating costs amounted to 1,715,728,355.95 RMB, up from 1,615,373,174.63 RMB in the previous year[14] - R&D expenses increased to 271,181,881.59 RMB, compared to 259,473,251.75 RMB in the prior year[14] - Sales expenses increased to 472,005,966.72 RMB, compared to 465,933,408.93 RMB in the previous year[14] - Interest expenses rose slightly to 21.63 million yuan, a 0.66% increase from the previous year[15] Investment and Income - Investment income decreased by 92.58% year-on-year, primarily due to smaller scale of matured financial products compared to the same period last year[5] - Fair value change income increased by 71.62% year-on-year, driven by unrealized gains from financial products[5] - Credit impairment losses surged by 1943.83% year-on-year, mainly due to increased bad debt provisions for receivables[5] - Investment income decreased significantly to 1.96 million yuan, down 92.58% year-on-year[15] - Cash inflow from investment activities totaled RMB 2.95 billion, up from RMB 2.43 billion in the prior year[18] - Cash outflow from investment activities increased to RMB 4.35 billion from RMB 2.42 billion in the same period last year[18] - Cash paid for investments surged to RMB 4.05 billion from RMB 2.12 billion in the same period last year[18] Shareholders and Equity - The total number of ordinary shareholders at the end of the reporting period is 40,991[6] - Li Wenmei, the largest shareholder, holds 20.32% of the company's shares, totaling 97,843,968 shares[6] - Wang Jihua, the second-largest shareholder, holds 10.30% of the company's shares, totaling 49,594,740 shares[6] - Guangzhou Huiyin Tianyue Equity Investment Fund Management Co., Ltd., a state-owned legal entity, holds 10.22% of the company's shares, totaling 49,195,579 shares[6] - The company's restricted shares increased by 37,371,992 shares during the reporting period, reaching a total of 111,183,968 shares[10] - The company's capital reserve increased by 92.43%, primarily due to capital premium from the private placement[5] Cash Flow - Cash flow from operating activities totaled 1.95 billion yuan, slightly higher than the previous year's 1.94 billion yuan[17] - Operating cash flow net amount for the quarter was RMB 173.32 million, compared to a negative RMB 36.26 million in the same period last year[18] - Total cash outflow from operating activities was RMB 1.78 billion, a decrease from RMB 1.98 billion in the previous year[18] - Net cash flow from financing activities was RMB 644.78 million, a significant improvement from a negative RMB 418.97 million in the previous year[18] - Cash and cash equivalents at the end of the period stood at RMB 263.58 million, down from RMB 732.32 million at the beginning of the period[18] - The company received RMB 864.08 million from capital absorption, a substantial increase from RMB 45.85 million in the same period last year[18] - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets was RMB 292.38 million, slightly lower than RMB 293.99 million in the previous year[18] - The company's cash and cash equivalents decreased by RMB 576.00 million during the quarter, compared to a decrease of RMB 428.11 million in the same period last year[18] Other Comprehensive Income - Other comprehensive income showed a negative value of -222,870.57 yuan, compared to a positive 2.22 million yuan in the same period last year[16] - Foreign exchange translation differences contributed -84,915.68 yuan to other comprehensive income[16]